Hostname: page-component-89b8bd64d-nlwjb Total loading time: 0 Render date: 2026-05-07T15:37:25.883Z Has data issue: false hasContentIssue false

A sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphoma

Published online by Cambridge University Press:  16 July 2015

JeenJoo S. Kang
Affiliation:
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA
Peter B. Dervan*
Affiliation:
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA
*
* Author for correspondence: P. B. Dervan, Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., Mail Code 164-30, Pasadena, CA 91125, USA. Tel.: (626 ) 395-6002; Fax: (626) 683-8753; E-mail: dervan@caltech.edu
Rights & Permissions [Opens in a new window]

Abstract

Means to cause an immunogenic cell death could lead to significant insight into how cancer escapes immune control. In this study, we screened a library of five pyrrole–imidazole polyamides coding for different DNA sequences in a model of B-cell lymphoma for the upregulation of surface calreticulin, a pro-phagocytosis signal implicated in immunogenic cell death. We found that hairpin polyamide 1 triggers the release of the damage-associated molecular patterns calreticulin, ATP and HMGB1 in a slow necrotic-type cell death. Consistent with this signaling, we observed an increase in the rate of phagocytosis by macrophages after the cancer cells were exposed to polyamide 1. The DNA sequence preference of polyamide 1 is 5′-WGGGTW-3′ (where W = A/T), indicated by the pairing rules and confirmed by the Bind-n-Seq method. The close correspondence of this sequence with the telomere-repeat sequence suggests a potential mechanism of action through ligand binding at the telomere. This study reveals a chemical means to trigger an inflammatory necrotic cell death in cancer cells.

Information

Type
Report
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Cambridge University Press 2015
Figure 0

Fig. 1. Screen of Py–Im polyamide library 1–6 for stimulation of surface calreticulin (CRT) in Raji cells. (a) Py–Im polyamide recognition of DNA minor groove and corresponding ball-and-stick notation. (b) Structures of compounds in polyamide library. (c) Surface expression of calreticulin measured by flow cytometry, median fluorescence normalized to non-treated control (NT). Cytotoxic controls doxorubicin (Dox, 5 μm), mitoxantrone (Mtx, 1 μm) and etoposide (Eto, 30 μm). (d) Dose dependence of cell surface CRT to polyamide 1 was measured by flow cytometry after 24 h treatment. Measurement and error bars of the standard deviation are in triplicate and representative of two independent experiments; asterisk indicates p < 0·05 by two-tailed Student's t test compared with NT.

Figure 1

Fig. 2. Preferred DNA-binding sequence of polyamide 1. (a) Polyamide 1b (SI Fig. 1b), the biotinylated analog of 1, was tested in a Bind-n-Seq assay and found to preferentially bind the described DNA sequence motif. (b) Affinity of 1 was assessed by a DNA thermal stabilization assay against dsDNA containing the telomeric-repeat sequence 5′-TTAGGG-3′. (c) Immunoblot of γ-H2AX and actin control after the indicated treatment.

Figure 2

Fig. 3. Treatment of Raji cells with polyamide 1 triggers anterograde CRT transport by a different mechanism than previously reported for anthracyclins. (a) Surface CRT was measured by flow cytometry after Raji cells were treated with 25 μm polyamide 1 for 12 or 24 h and Brefeldin A (B) for the final 12 h. (b) Co-chaperone ERp57 was measured on the cell surface by flow cytometry after 24 h treatment with 1 at 25 μm. (c) Caspase inhibitor Z-VAD-fmk (Z, 10 μm) and polyamide 1 (25 μm) were dosed together for 24 h and assessed by flow cytometry for surface CRT. (d) Immunoblots for PARP cleavage and actin control after the indicated treatments are shown. All flow cytometry analyses were done in triplicate and are representative of at least two independent experiments. Error bars show standard deviations and asterisks mark statistically significant changes (p < 0·05) by two-tailed Student's t test compared with non-treatment (unless another comparator is marked).

Figure 3

Fig. 4. Raji cells undergo a slow, necrotic type cell death after treatment with polyamide 1. (a) Caspase 3/7 activity was assessed by a luciferase assay after the indicated treatment. Measurement is representative of two independent experiments and error bars show standard deviations of triplicate measurement. (b) Cellular metabolism as a proxy for cytotoxicity was measured with a WST-1 assay. Cytotoxic controls etoposide (Eto, 30 μm) and doxorubicin (Dox, 5 μm) were included. Measurements were normalized to non-treatment. Graph is representative of two independent experiments and error bars represent standard deviations of technical quadruplicate. (c) Flow cytometry assessment of Raji cells treated with the indicated compounds for 24 h and stained for plasma membrane permeability (7-AAD) and phosphatidylserine exposure (Annexin V). Live: lower left; early necrotic: upper left; secondary necrotic: upper right; apoptotic: lower right. Representative plots shown of triplicate measurements from two independent experiments. (d) Assessment as in (b) after 12, 24 and 48 h exposure to polyamide 1 at 25 μm.

Figure 4

Fig. 5. Immunogenic signaling is triggered by polyamide 1 treatment. (a) CRT was measured by flow cytometry after 24 and 48 h treatment with 1 or 2 at 25 μm. (b) Extracellular ATP was measured by a bioluminescence assay after the same treatment. (c) HMGB1 in the supernatant was measured by ELISA after treatment as in (a) and (b). CRT flow cytometry and HMGB1 ELISA were measured in triplicate from at least two independent experiments. ATP was measured in quadruplicate in three independent experiments. Error bars show standard deviations and asterisks indicate statistically significant increases (two-tailed Student's t test, p < 0·05) compared with non-treatment.

Figure 5

Fig. 6. Treatment of cells with 1 increases phagocytosis by human macrophages. (a) Schematic diagram of fluorescence-revealed phagocytosis using the pH-sensitive pHrodo dye. (b) Raji cells treated with the indicated compound at 25 μm for 24 or 48 h were incubated with human macrophages for 2·5 h. Fluorescein+ cells were assessed by flow cytometry for double-positive cells to determine % phagocytosis. (c) Raji cells were treated with a lower dose of 5 μm of 1 for 24 and 48 h and assessed for phagocytosis by macrophages in the same manner as in (b). (d) Fluorescent images of cells prepared as in (B) are shown. Human macrophages are marked green, free Raji cells are gray in the brightfield composite image, and magenta-colored bodies inside macrophages are phagocytosed Raji cells with activated pHrodo. Yellow box in top row is magnified in bottom row images. (e) The cell lines A549, K562 and PC3 were treated with polyamide 1 for 24 h and screened by flow cytometry for surface CRT. Measurements and standard deviations are in technical triplicate and biological duplicate. (f) A549 lung carcinoma cells treated with 1 for 24 h was subjected to human macrophages as described above. Graphs show mean and standard deviation from three independent experiments for (b), (c), (e) and (f). Asterisks indicate statistically significant increases (Student's two-tailed t test, p < 0·05) compared with the non-treated condition. Images in (d) are representative of two independent experiments.

Supplementary material: PDF

Kang and Dervan supplementary material

Kang and Dervan supplementary material 1

Download Kang and Dervan supplementary material(PDF)
PDF 331.2 KB